Wendy Arnott

1.2k total citations · 1 hit paper
11 papers, 972 citations indexed

About

Wendy Arnott is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Wendy Arnott has authored 11 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Psychiatry and Mental health and 3 papers in Pharmacology. Recurrent topics in Wendy Arnott's work include Blood Pressure and Hypertension Studies (4 papers), Schizophrenia research and treatment (3 papers) and Heart Rate Variability and Autonomic Control (2 papers). Wendy Arnott is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Schizophrenia research and treatment (3 papers) and Heart Rate Variability and Autonomic Control (2 papers). Wendy Arnott collaborates with scholars based in Canada, Belgium and United States. Wendy Arnott's co-authors include Guy Chouinard, B. Jones, G. William MacEwan, A. Labelle, Linda Beauclair, D. M. Bloom, Gary Remington, Donald Addington, G Chouinard and Yves Lacourcière and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Antimicrobial Agents and Chemotherapy and American Journal of Hypertension.

In The Last Decade

Wendy Arnott

11 papers receiving 899 citations

Hit Papers

A Canadian Multicenter Placebo-Controlled Study of Fixed ... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Arnott Canada 8 711 192 150 135 130 11 972
Thomas J. Arndt United States 8 760 1.1× 117 0.6× 171 1.1× 147 1.1× 61 0.5× 8 1.1k
Dan Zimbroff United States 12 890 1.3× 125 0.7× 266 1.8× 317 2.3× 63 0.5× 21 1.3k
Cristiana Gassmann-Mayer United States 16 1.2k 1.6× 195 1.0× 173 1.2× 162 1.2× 45 0.3× 16 1.6k
Philipp Rothe Germany 10 1.1k 1.5× 193 1.0× 242 1.6× 234 1.7× 62 0.5× 17 1.4k
Michelle Kramer United States 15 1.6k 2.3× 181 0.9× 283 1.9× 254 1.9× 75 0.6× 27 1.9k
Joris Berwaerts United States 23 880 1.2× 84 0.4× 212 1.4× 119 0.9× 136 1.0× 49 1.4k
Edmund P. Harrigan United States 12 893 1.3× 118 0.6× 163 1.1× 408 3.0× 471 3.6× 28 1.6k
Mary Anne Dellva United States 16 831 1.2× 171 0.9× 236 1.6× 185 1.4× 67 0.5× 44 1.3k
C. Barnas Austria 19 700 1.0× 70 0.4× 197 1.3× 65 0.5× 54 0.4× 61 1.2k
M. Andrew Berisford United States 9 852 1.2× 57 0.3× 212 1.4× 149 1.1× 49 0.4× 11 1.2k

Countries citing papers authored by Wendy Arnott

Since Specialization
Citations

This map shows the geographic impact of Wendy Arnott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Arnott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Arnott more than expected).

Fields of papers citing papers by Wendy Arnott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Arnott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Arnott. The network helps show where Wendy Arnott may publish in the future.

Co-authorship network of co-authors of Wendy Arnott

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Arnott. A scholar is included among the top collaborators of Wendy Arnott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Arnott. Wendy Arnott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lefèbvre, Jean, et al.. (1994). Treatment of Ambulatory Hypertensives With Nebivolol or Hydrochlorothiazide Alone and in Combination. American Journal of Hypertension. 7(2). 137–145. 36 indexed citations
2.
Lefèbvre, Jean, et al.. (1994). A DOUBLE-BLIND CROSSOVER COMPARISON OF NEBIVOLOL AND LISINOPRIL IN THE TREATMENT OF AMBULATORY HYPERTENSION. American Journal of Therapeutics. 1(1). 74–80. 19 indexed citations
3.
Lacourcière, Yves & Wendy Arnott. (1994). Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.. PubMed. 8(4). 283–8. 38 indexed citations
4.
Chouinard, G & Wendy Arnott. (1993). Clinical review of risperidone.. PubMed. 38 Suppl 3. S89–95. 63 indexed citations
5.
Chouinard, Guy, B. Jones, Gary Remington, et al.. (1993). A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients. Journal of Clinical Psychopharmacology. 13(1). 25???40–25???40. 704 indexed citations breakdown →
6.
Lacourcière, Yves, Luc Poirier, Jean Lefèbvre, Pierre Provencher, & Wendy Arnott. (1992). Comparative Effects of a New Cardioselective Beta‐Blocker Nebivolol and Nifedipine Sustained‐Release on 24‐Hour Ambulatory Blood Pressure and Plasma Lipoproteins. The Journal of Clinical Pharmacology. 32(7). 660–666. 34 indexed citations
7.
Gawel, Marek, J Kreeft, Robert F. Nelson, Denis Simard, & Wendy Arnott. (1992). Comparison of the Efficacy and Safety of Flunarizine to Propranolol in the Prophylaxis of Migraine. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 19(3). 340–345. 56 indexed citations
8.
Chouinard, G & Wendy Arnott. (1992). ANTIDYSKINETIC EFFECT OF RISPERIDONE IN CHRONIC SCHIZOPHRENIC PATIENTS. Clinical Neuropharmacology. 15. 266B–266B. 7 indexed citations
9.
Arnott, Wendy. (1992). Double-Blind Comparison of the Efficacy and Safety of Astemizole and Loratadine in the Treatment of Seasonal Allergic Rhinitis. Clinical Drug Investigation. 4(4). 336–345. 1 indexed citations
10.
Drouin, Michel, et al.. (1991). Clinical evaluation of the efficacy and safety of noberastine, a new H1 antagonist, in seasonal allergic rhinitis: A placebo-controlled, dose-response study. Journal of Allergy and Clinical Immunology. 88(6). 926–934. 10 indexed citations
11.
Waite, Nancy M., David J. Edwards, Wendy Arnott, & L H Warbasse. (1989). Effects of ciprofloxacin on testosterone and cortisol concentrations in healthy males. Antimicrobial Agents and Chemotherapy. 33(11). 1875–1877. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026